Cardiomyopathies

"Cardiomyopathies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).

Descriptor ID	D009202
MeSH Number(s)	C14.280.238
Concept/Terms	Cardiomyopathies Cardiomyopathies Cardiomyopathy Myocardial Diseases Disease, Myocardial Diseases, Myocardial Myocardial Disease Myocardiopathies Myocardiopathy Cardiomyopathies, Secondary Cardiomyopathies, Secondary Cardiomyopathy, Secondary Secondary Cardiomyopathies Secondary Cardiomyopathy Secondary Myocardial Diseases Disease, Secondary Myocardial Diseases, Secondary Myocardial Myocardial Disease, Secondary Secondary Myocardial Disease Myocardial Diseases, Secondary Cardiomyopathies, Primary Cardiomyopathies, Primary Cardiomyopathy, Primary Primary Cardiomyopathies Primary Cardiomyopathy Primary Myocardial Diseases Myocardial Diseases, Primary Disease, Primary Myocardial Diseases, Primary Myocardial Myocardial Disease, Primary Primary Myocardial Disease

Below are MeSH descriptors whose meaning is more general than "Cardiomyopathies".

Diseases [C]
Cardiovascular Diseases [C14]
Heart Diseases [C14.280]
Cardiomyopathies [C14.280.238]

Below are MeSH descriptors whose meaning is more specific than "Cardiomyopathies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Cardiomyopathies" by people in this website by year, and whether "Cardiomyopathies" was a major or minor topic of these publications.

Bar chart showing 57 publications over 24 distinct years, with a maximum of 6 publications in 2023

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	1	0	1
2002	1	0	1
2003	1	0	1
2004	1	0	1
2006	2	0	2
2007	2	0	2
2008	2	1	3
2009	1	1	2
2010	1	0	1
2011	2	0	2
2012	2	1	3
2013	3	0	3
2014	1	0	1
2015	2	0	2
2016	3	0	3
2017	1	1	2
2018	4	0	4
2019	5	0	5
2020	3	0	3
2021	2	0	2
2022	3	0	3
2023	6	0	6
2024	1	0	1
2025	3	0	3

Below are the most recent publications written about "Cardiomyopathies" by people in Profiles.

Montoya-Uribe V, Choubey P, Walton CB, Glibetic N, Seok Yang W, Aan FJ, Lindsey S, Peplowska K, Hernandez BY, Ramos JW, Matter ML. Peptidyl-tRNA hydrolase 2 is a negative regulator of peripartum cardiomyopathy with heart failure in female mice. Nat Commun. 2025 Dec 19; 17(1):1091.

View in: PubMed
Ruberg FL, Teruya S, Helmke S, Smiley DA, Fine D, Kurian D, Raiszadeh F, Prokaeva T, Spencer B, Wong S, Pandey S, Blaner WS, DeLuca A, Johnson LL, Kinkhabwala MP, Leb J, Mintz A, LaValley MP, Einstein AJ, Cohn E, Gallegos C, Murtagh G, Kelly JW, Miller EJ, Maurer MS. Transthyretin Cardiac Amyloidosis in Older Black and Hispanic Individuals With Heart Failure. JAMA Cardiol. 2025 Oct 01; 10(10):1034-1043.

View in: PubMed
Loayza Pintado J, Ajani T, Hernandez D, Cobos E. A Rare Culprit or an Elusive Culprit in Disguise? Unraveling Wild-Type ATTR Cardiac Amyloidosis in Heart Failure With Reduced Ejection Fraction. J Investig Med High Impact Case Rep. 2025 Jan-Dec; 13:23247096251345712.

View in: PubMed
Pressley KR, Naseem Y, Nalawade S, Forsthuber TG. The distinct functions of MIF in inflammatory cardiomyopathy. Front Immunol. 2025; 16:1544484.

View in: PubMed
Ibeh C, Kulick ER, Boehme AK, Friedman AM, Miller EC, Bello NA. Incident stroke in individuals with peripartum cardiomyopathy. Am Heart J. 2024 09; 275:138-140.

View in: PubMed
Wardhere A, Bampatsias D, Cohn E, Fine D, Freitas C, Gallegos C, Helmke S, Ionescu N, Ivrose J, Rodriguez C, Sabogal N, Fils S, Henry T, Teruya S, Ullah I, Kurian D, Raiszadeh F, Miller EJ, Ruberg FL, Maurer MS. Unlocking Diversity in Cardiovascular Clinical Research: Lessons from the Screening for Cardiac Amyloidosis With Nuclear Imaging in a Minority Populations Study. J Card Fail. 2024 11; 30(11):1507-1511.

View in: PubMed
Azad H, Wen T, Bello NA, Booker WA, Purisch S, D'Alton ME, Friedman AM. Peripartum cardiomyopathy delivery hospitalization and postpartum readmission trends, risk factors, and outcomes. Pregnancy Hypertens. 2023 Dec; 34:116-123.

View in: PubMed
Segan L, Chieng D, Sugumar H, Voskoboinik A, Ling LH, Costello B, Azzopardi S, Nderitu Z, Parameswaran R, Amerena J, McLellan AJ, Lee G, Morton J, Joseph S, Wong M, Taylor A, Kalman JM, Kistler PM, Prabhu S. The impact of age on ablation outcomes in AF-mediated cardiomyopathy. J Cardiovasc Electrophysiol. 2023 10; 34(10):2065-2075.

View in: PubMed
Madhani A, Sabogal N, Massillon D, Paul LD, Rodriguez C, Fine D, Helmke S, Winburn M, Kurian D, Raiszadeh F, Teruya S, Cohn E, Einstein AJ, Miller EJ, Connors LH, Maurer MS, Ruberg FL. Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study. J Am Heart Assoc. 2023 08; 12(15):e028973.

View in: PubMed
Hara A, Tallquist MD. Fibroblast and Immune Cell Cross-Talk in Cardiac Fibrosis. Curr Cardiol Rep. 2023 06; 25(6):485-493.

View in: PubMed

People

Explore

Similar Concepts

Top Journals